News tagged with pharmaceutical companies

FDA: Omontys injection pulled from market

(HealthDay)—Affymax Inc. of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited of Deerfield, Ill., have voluntarily recalled all lots of Omontys Injection, used to treat anemia in adult dialysis ...

Feb 26, 2013
popularity not rated yet | comments 0

Antidepressants alone are not enough

We should reconsider how we use antidepressants more effectively. The latest studies have shown that antidepressants restore the capacity of certain areas of the brain to repair abnormal neural pathways. According to neuroscientist ...

Feb 22, 2013
popularity 5 / 5 (4) | comments 2

Danish Novo Nordisk profit surges

Danish pharmaceutical company Novo Nordisk A/S on Thursday reported a 23 percent growth in fourth-quarter net profit on strong sales of diabetic drugs and gave a positive outlook as regulators worldwide begin to approve its ...

Jan 31, 2013
popularity not rated yet | comments 0

Linagliptin: Once again, no proof of added benefit

Linagliptin (trade name Trajenta) has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market ...

Jan 30, 2013
popularity not rated yet | comments 0

Perampanel for epilepsy: No proof of added benefit

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In an early benefit assessment according ...

Jan 30, 2013
popularity not rated yet | comments 0

Care transition initiative decreases rehospitalizations

(HealthDay)—Communities instituting quality improvement initiatives for care transitions see significant declines in the rate of 30-day rehospitalizations and hospitalizations, according to a study published ...

Jan 23, 2013
popularity not rated yet | comments 0

Big Pharma cashes in on HGH abuse

An Associated Press investigation shows that a federal crackdown on illicit foreign supplies of human growth hormone has failed to stop rampant misuse, and instead has driven record sales of the drug by some of the world's ...

Dec 21, 2012
popularity not rated yet | comments 0